Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease

The effect of early-onset enzyme replacement therapy on renal morphologic features in Fabry disease is largely unknown. Here, we evaluated the effect of 5 years of treatment with agalsidase alfa or agalsidase beta in 12 consecutive patients age 7–33 years (median age, 16.5 years). We performed renal...

Full description

Saved in:
Bibliographic Details
Main Authors: Tøndel, Camilla, Bostad, Leif, Larsen, Kristin Kampevold, Hirth, Asle, Vikse, Bjørn Egil, Houge, Gunnar, Svarstad, Einar
Format: Artigo
Language:Inglês
Published: American Society of Nephrology 2012
Subjects:
Clinical Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537211/
https://ncbi.nlm.nih.gov/pubmed/23274955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2012030316
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items